![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Metro Giulio Mottolese Marcella Fabi Alessandra
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.9, Iss.15, 2008-10, pp. : 2583-2601
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Trastuzumab: In HER2 and Hormone Receptor Co-Positive Metastatic Breast Cancer
By Orman Jennifer S. Perry Caroline M.
Drugs, Vol. 67, Iss. 18, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Trastuzumab: In HER2-Positive Metastatic Gastric Cancer
By Croxtall Jamie D. McKeage Kate
Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Gullo Giuseppe Bettio Daniela Torri Valter Masci Giovanna Salvini Piermario Santoro Armando
Investigational New Drugs, Vol. 27, Iss. 2, 2009-04 ,pp. :